Trastuzumab Terminated Phase 3 Trials for Metastasis / Sur-expressing Her2-neu / Breast Cancer Treatment

TerminatedTreatment3 IdentifierTitleDrugs
NCT01613482TraStuzumAb-Radiotherapy : Impact on the Cerebral Prevention
NCT00625898BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
NCT00440622Study of Gemcitabine and Herceptin Versus Xeloda and Herceptin in HER-2 (+) Metastatic Breast Cancer Patients